Cover Image
市場調查報告書

全球輸液設備市場預測:輸液幫浦,胰島素幫浦,腸道餵食幫浦

Global Infusion Devices Market Forecast to 2027: Infusion Pumps, Insulin Pumps, Enteral Feeding Pumps, Other Infusion Pumps

出版商 Visiongain Ltd 商品編碼 235219
出版日期 內容資訊 英文 231 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球輸液設備市場預測:輸液幫浦,胰島素幫浦,腸道餵食幫浦 Global Infusion Devices Market Forecast to 2027: Infusion Pumps, Insulin Pumps, Enteral Feeding Pumps, Other Infusion Pumps
出版日期: 2017年12月15日 內容資訊: 英文 231 Pages
簡介

本報告提供全球輸液設備市場相關調查分析,提供二次市場收益預測,促進因素·阻礙因素,主要產品,SWOT分析,波特的五力分析等系統性資訊。

第1章 報告概要

第2章 輸液幫浦的簡介

  • 輸液的種類
  • 幫浦的種類
  • 輸液幫浦的歷史
  • 輸液幫浦成為有用的臨床環境
  • 輸液幫浦的優點和缺點

第3章 輸液幫浦:全球市場

  • 全球醫療設備市場
  • 輸液幫浦市場定義
  • 全球輸液幫浦市場
  • 全球輸液幫浦市場預測
  • 輸液幫浦市場:胰島素幫浦主導
  • 市場佔有率的變動
  • 全球輸液幫浦市場:促進因素·阻礙因素

第4章 主要國家市場

  • 全球輸液幫浦市場各地區明細
  • 輸液幫浦的各國市場預測
  • 美國
  • EU
  • 日本
  • 中國
  • 印度
  • 巴西
  • 韓國
  • 俄羅斯

第5章 胰島素幫浦次市場

  • 簡介
  • 胰島素幫浦的胰島素
  • 胰島素幫浦的優點和缺點
  • 胰島素注射液·類似體
  • 胰島素輸液幫浦次市場
  • 胰島素幫浦次市場的各地區明細
  • 胰島素幫浦次市場:銷售額預測
  • 胰島素幫浦次市場的主要產品
  • 胰島素幫浦主要開發中產品
  • 胰島素幫浦次市場:促進因素·阻礙因素
  • 已開發國家:採用增加
  • 胰島素幫浦的償付提供長期性的經濟利益
  • 新興市場進入的時候高額的技術障礙
  • 胰島素幫浦的安全上的風險

第6章 腸道餵食幫浦次市場

  • 簡介
  • 結腸營養法
  • 腸道餵食幫浦次市場:銷售額預測
  • 腸道餵食幫浦次市場的主要產品
  • 腸道餵食幫浦次市場:促進因素·阻礙因素

第7章 其他輸液幫浦次市場

  • 其他輸液幫浦次市場定義
  • 其他輸液幫浦次市場
  • 其他輸液幫浦次市場:銷售額預測
  • 化療用幫浦
  • PCA (自我調節止痛) 事情幫浦

第8章 競爭技術分析

  • 藥物輸送技術
  • 藥物輸送技術類型
  • 全球藥物輸送技術市場
  • 藥物輸送技術市場各地區明細
  • 全球藥物輸送技術市場預測
  • 主要的藥物輸送開發中產品

第9章 輸液幫浦市場定性分析

  • SWOT分析
  • 優勢
  • 弱點
  • 機會
  • 威脅
  • 波特的五力分析

第10章 結論

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0268

The global infusion devices market is expected to grow at a CAGR of 6.2% in the first half of the forecast period. In 2016, the insulin pumps submarket held the 31% of the global infusion devices market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 231-page report you will receive 83 tables and 65 figures - all unavailable elsewhere.

The 231-page report provides clear detailed insight into the global infusion devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global Medical Infusion Devices market forecasts to 2027
  • This report also breaks down the revenue forecast for global infusion devices market by these submarkets :
    • Insulin pumps,
    • Enteral feeding pumps
    • Other pumps (a grouped category inclusive of chemotherapy pumps and PCA infusion pumps)

image1

This report analyses and dicusses the drivers and restraints for each submarket.

  • Our work also shows individual revenue forecasts to 2027 for 12 national markets:
    • United States (US)
    • Japan
    • EU leaders - Germany, France, the UK, Italy and Spain (EU5)
    • BRIC nations - Brazil, Russia, India and China.
    • South Korea
    • RoW
  • Our work also shows individual revenue forecasts to 2027 for the Global Drug Delivery Technology market, broken down by these submarkets:
    • Oral drug delivery
    • Inhalation drug delivery
    • Injectable/implantable drug delivery
    • Transdermal drug delivery
    • Ocular drug delivery
    • Nasal drug delivery
  • This report discusses the leading products in the global infusion devices market, from several leading companies, including:
    • ALCOR Scientific
    • Altea Therapeutics
    • Animas Corporation
    • B.Braun
    • Baxter
    • CareFusion
    • Cellnovo
    • Covidien
    • D. Medical Industries
    • Danone Nutricia
    • Debiotech
    • Disetronic (Roche)
    • Fresenius Kabi
    • Hospira
    • Insulet Corporation
    • Johnson & Johnson
    • Medline
    • MedSolve Technologies
    • Medtronic
    • Q Core Medical
    • Roche
    • Smiths Medical
    • SOOIL
    • Tandem Diabetes Care
    • Valeritas
    • Zevex
  • This report provides a SWOT analysis of the major strengths and weaknesses of the market, together with the opportunities available and the key threats faced. Moreover, this report proves Porter's Five Forces Analysis of the global infusion devices market.

Visiongain's study is for everybody needing commercial analyses for the Infusion Pumps market and leading companies. You will find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 World Infusion Pumps Market Segmentation
  • 1.2 Why You Should Read This Report
  • 1.3 How This Report Delivers: Chapter Outline
  • 1.4 Key Questions Answered by This Analytical Report
  • 1.5 Who is This Report For?
  • 1.6 Methodology
  • 1.7 Frequently Asked Questions (FAQ)
  • 1.8 Associated Visiongain Reports
  • 1.9 About Visiongain

2. Introduction to Infusion Pumps

  • 2.1 Types of Infusion
  • 2.2 Types of Pumps
    • 2.2.1 Gravity Controlled Infusion
    • 2.2.2 Positive Displacement Pumps
    • 2.2.3 Drip Rate Pumps
    • 2.2.4 Volumetric Pumps
    • 2.2.5 Syringe Pumps
    • 2.2.6 Multi-Channel Pumps
    • 2.2.7 Ambulatory Pumps
  • 2.3 History of Infusion Pumps
  • 2.4 What Clinical Settings Will Infusion Pumps Be Useful For?
    • 2.4.1 Infusion Pumps for Diabetes
    • 2.4.2 Infusion Pumps for Chemotherapy
    • 2.4.3 Infusion Pumps for Analgesia
    • 2.4.4 Infusion Pumps for Enteral Feeding
    • 2.4.5 Other Uses for Infusion Pumps
  • 2.5 Advantages and Disadvantages of Infusion Pumps

3. Infusion Pumps: World Market, 2016-2027

  • 3.1 World Medical Devices Market, 2016-2027
  • 3.2 Infusion Pump Market Definition
  • 3.3 World Infusion Pumps Market, 2016
  • 3.4 World Infusion Pumps Market Forecast, 2016-2027
    • 3.4.1 The Infusion Pumps Market Forecast, 2016-2021
    • 3.4.2 The Infusion Pumps Market Forecast, 2022-2027
  • 3.5 The Infusion Pumps Market: Insulin Pumps Are Market Leaders
  • 3.6 How Will Segmental Market Shares Change to 2027?
  • 3.7 World Infusion Pumps Market: Drivers and Restraints, 2016-2027
    • 3.7.1 Ageing Population and Rising Incidences of Chronic Diseases
    • 3.7.2 Advancement in Infusion Pump Technologies
    • 3.7.3 A Shift towards Home Care
    • 3.7.4 Safety Risk and Stringent Approval Process

4. Leading National Markets, 2016-2027

  • 4.1 Regional Breakdown of World Infusion Pumps Market, 2016
  • 4.2 Infusion Pumps National Market Forecast, 2016-2027
    • 4.2.1 How Will National Market Shares Change to 2027?
  • 4.3 US Infusion Pumps Market, 2016-2027
    • 4.3.1 US Medical Device Regulations, 2016-2027
    • 4.3.2 US Infusion Pumps Market Forecast, 2016-2027
  • 4.4 EU Infusion Pumps Market 2016
    • 4.4.1 EU Medical Device Approval and Regulations
    • 4.4.2 The EU Approval and Regulation System
    • 4.4.3 Changes in the New EU Medical Device Regulations
    • 4.4.4 Post Marketing Surveillance in the EU
    • 4.4.5 EU Infusion Pumps Market Forecast, 2016-2027
    • 4.4.6 How Will EU Market Shares Change to 2027?
    • 4.4.7 German Infusion Pumps Market Forecast, 2016-2027
    • 4.4.8 French Infusion Pumps Market Forecast, 2016-2027
    • 4.4.9 UK Infusion Pumps Market Forecast, 2016-2027
    • 4.4.10 Italian Infusion Pumps Market Forecast, 2016-2027
    • 4.4.11 Spanish Infusion Pumps Market Forecast, 2016-2027
  • 4.5 Japanese Infusion Pumps Market, 2016
    • 4.5.1 Japan: Improved Approval Process
    • 4.5.2 Japanese Infusion Pumps Market Forecast, 2016-2027
  • 4.6 Chinese Infusion Pumps Market, 2016
    • 4.6.1 Chinese Infusion Pumps Market Forecast, 2016-2027
    • 4.6.2 China's 12th Five-Year-Plan (2010-2015)
    • 4.6.3 New Policies Favouring Domestically-Made Medical Devices
  • 4.7 Indian Infusion Pumps Market 2016
    • 4.7.1 Indian Infusion Pumps Market Forecast, 2016-2027
  • 4.8 Brazilian Infusion Pumps Market, 2016
    • 4.8.1 Brazilian Infusion Pumps Market Forecast, 2016-2027
  • 4.9 South Korean Infusion Pumps Market, 2016
    • 4.9.1 South Korean Infusion Pumps Market Forecast, 2016-2027
  • 4.10 Russian Infusion Pumps Market, 2016
    • 4.10.1 Russian Infusion Pumps Market Forecast, 2016-2027

5. Insulin Pumps Submarket, 2016-2027

  • 5.1 Introduction to Insulin Pumps
  • 5.2 Insulin in Insulin Pumps
    • 5.2.1 Bolus Infusion
    • 5.2.2 Basal Infusion
  • 5.3 Advantages and Disadvantages of Insulin Pumps
  • 5.4 Human Insulin and Analogues
  • 5.5 Insulin Infusion Pumps Submarket, 2016
  • 5.6 Insulin Pumps Submarket Regional Breakdown, 2016
  • 5.7 Insulin Pumps Submarket: Sales Forecast, 2016-2027
  • 5.8 Insulin Pumps Submarket: Sales Forecast, 2016-2021
  • 5.9 Insulin Pumps Submarket: Sales Forecast, 2022-2027
  • 5.10 Leading Products in Insulin Pumps Submarket, 2016
    • 5.10.1 MiniMed (Medtronic)
    • 5.10.2 OmniPod (Insulet Corporation)
    • 5.10.3 OneTouch Ping (Animas Corporation)
    • 5.10.4 Accu-Chek Spirit (Disetronic, subsidiary of Roche)
    • 5.10.5 t:Slim (Tandem Diabetes Care)
    • 5.10.6 Animas Vibe (Animas Acquired by Johnson & Johnson)
    • 5.10.7 DANA Diabecare IISG (SOOIL)
    • 5.10.8 SpringZone (D. Medical Industries)
    • 5.10.9 Cellnovo (Cellnovo)
    • 5.10.10 V-Go (Valeritas)
  • 5.11 Key Insulin Pumps Pipeline Products, 2016
    • 5.11.1 Finesse Personal Insulin Patch (Johnson & Johnson)
    • 5.11.2 SOLO MicroPump (Roche)
    • 5.11.3 Artificial Pancreas (Juvenile Diabetes Research Foundation)
    • 5.11.4 Freehand (MedSolve Technologies)
    • 5.11.5 NanoPump (Debiotech)
    • 5.11.6 PassPort (Altea Therapeutics)
    • 5.11.7 NiliPatch (D. Medical Industries)
  • 5.12 Insulin Pumps Submarket: Drivers and Restraints, 2016-2027
    • 5.12.1 Increased Competition Drives Innovation
    • 5.12.2 Collaborating to Address Unmet Needs
    • 5.12.3 A Strong R&D Pipeline Will Drive the Market
    • 5.12.4 Diabetes Globalisation: A Rapidly Increasing Incidence
  • 5.13 Developed Economies: Increasing Adoption
  • 5.14 Reimbursement of Insulin Pumps Will Give Long-Term Economic Benefits
  • 5.15 More Expensive Technology Presents a Challenge When Entering Emerging Markets
  • 5.16 Security Risks with Insulin Pumps

6. Enteral Feeding Pumps Submarket, 2016-2027

  • 6.1 Introduction to Enteral Feeding Pumps
    • 6.1.1 Clinical Settings That May Require Enteral Feeding
    • 6.1.2 Advantages and Disadvantages of Enteral Feeding
  • 6.2 Delivery of Enteral Feeding
    • 6.2.1 Tube Placements Used in Enteral Feeding
    • 6.2.2 Enteral Feeding at Home
    • 6.2.3 Enteral Feeding Pumps Submarket, 2016
    • 6.2.4 Enteral Feeding Pumps Submarket Regional Breakdown, 2016
  • 6.3 Enteral Feeding Pumps Submarket: Sales Forecast, 2016-2027
    • 6.3.1 Enteral Feeding Pumps Submarket: Sales Forecast, 2016-2021
    • 6.3.2 Enteral Feeding Pumps Submarket: Sales Forecast, 2022-2027
  • 6.4 Leading Products in Enteral Feeding Pump Submarket 2016
    • 6.4.1 Compat DualFlo Enteral Feeding Pump (Acquired by Medline)
    • 6.4.2 Sentinel Enteral Feeding Pump (ALCOR Scientific)
    • 6.4.3 EnteraLite Infinity Enteral Feeding Pump (Zevex /Moog)
    • 6.4.4 APPLIX Vision (Fresenius Kabi)
    • 6.4.5 MiniFlo (Fresenius Kabi)
    • 6.4.6 Nutricia FloCare Infinity Pump (Danone Nutricia)
    • 6.4.7 Sapphire (Q Core Medical)
    • 6.4.8 Kangaroo Joey Enteral Feeding Pump (Covidien)
    • 6.4.9 Other Notable Enteral Feeding Pumps
  • 6.5 Enteral Feeding Pumps Submarket: Drivers and Restraints, 2016-2027
    • 6.5.1 Cost-Effective, Portable and Safer Products Will Drive Growth
    • 6.5.2 Growing World Geriatric Population and Prevalence of Chronic Diseases
    • 6.5.3 Increasing Demand for Homecare Solutions and Portability
    • 6.5.4 Exit of Abbott in the US Enteral Feeding Market in 2015
    • 6.5.5 Introduction of ISO's Standards for Small-Bore Connectors
    • 6.5.6 Replacement of Pumps and Sales of Disposable Feeding Sets Will Sustain Market Revenue
    • 6.5.7 Highly Competitive Market with High Barriers to Entry

7. Other Infusion Pumps Submarket, 2016-2027

  • 7.1 Other Infusion Pumps Submarket Definition
  • 7.2 Other Infusion Pumps Submarket, 2016
  • 7.3 Other Infusion Pumps Submarket: Sales Forecast, 2016-2027
  • 7.4 Chemotherapy Pumps
  • 7.5 Advantages and Disadvantages of Chemotherapy Pumps
  • 7.6 Leading Drugs in the Oncology Therapeutics Market, 2016
  • 7.7 The Chemotherapy Pumps Market, 2016
  • 7.8 Leading Products in Chemotherapy Pumps Market, 2016
    • 7.8.1 Infusor Infusion Pump (Baxter)
    • 7.8.2 CODMAN 3000 (Johnson & Johnson)
    • 7.8.3 Optima MS (Fresenius Kabi)
    • 7.8.4 CADD Legacy-1 (Smiths Medical)
    • 7.8.5 Other Notable Chemotherapy Pumps
  • 7.9 Chemotherapy Pumps Market: Drivers and Restraints, 2016-2027
  • 7.10 Patient Controlled Analgesia (PCA) Pumps
    • 7.10.1 Clinical Settings Where PCA Pumps Are Used
    • 7.10.2 How Does a PCA Pump Work?
    • 7.10.3 Advantages and Disadvantages of PCA Pumps
  • 7.11 Narcotic Drugs
  • 7.12 Leading Products in the PCA Pumps Market 2016
    • 7.12.1 LifeCare PCA 7.0 with Hospira MedNet Software (Hospira)
    • 7.12.2 Alaris PCA (CareFusion)
    • 7.12.3 Baxter PCA II (Baxter)
    • 7.12.4 Curlin PainSmart IOD Pain Management System (B.Braun)
    • 7.12.5 CADD-Solis Infusion Pump (Smiths Medical)
    • 7.12.6 Other Notable PCA Pumps
  • 7.13 PCA Pumps Market: Drivers and Restraints, 2016-2027

8. Competing Technology Analysis, 2016-2027

  • 8.1 Drug Delivery Technologies
  • 8.2 Types of Technologies for Drug Delivery
    • 8.2.1 Sustained/Controlled Release Systems
    • 8.2.2 Injection
    • 8.2.3 Needle Free Injections
    • 8.2.4 Pulmonary, Buccal and Nasal Delivery
    • 8.2.5 Pills and Capsules
  • 8.3 World Drug Delivery Technologies Market, 2016
  • 8.4 Drug Delivery Technologies Market Regional Breakdown, 2016
  • 8.5 World Drug Delivery Technologies Market Forecast, 2016-2027
  • 8.6 Key Drug Delivery Pipeline Products, 2016

9. Qualitative Analysis of the Infusion Pumps Market, 2016-2027

  • 9.1 SWOT Analysis of World Infusion Pumps Market, 2016-2027
  • 9.2 Strengths
    • 9.2.1 Highly Accurate Dosing at Regular Intervals
    • 9.2.2 Improved Quality of Life and Less Hospital Visits
    • 9.2.3 Used in a Wide Range of Clinical Settings
  • 9.3 Weaknesses
    • 9.3.1 Safety Concerns Will Call for Stricter Regulation
    • 9.3.2 Discomfort May Discourage Potential Users
    • 9.3.3 Expensive Technologies May Restrain the Market
  • 9.4 Opportunities
    • 9.4.1 Emerging Economies Are Growing
    • 9.4.2 Patient Demographics
    • 9.4.3 High Demand for Technological Advancements
    • 9.4.4 Drugs Coming Off-Patent Will Help to Drive the Market
  • 9.5 Threats
    • 9.5.1 Poor Economic Conditions in Key Regions of the Market
    • 9.5.2 Cost Effectiveness May Be Difficult to Prove
    • 9.5.3 Regulatory Bodies Can Make Entry to Market Difficult
    • 9.5.4 Technological Advances in Drug Delivery May Surpass Those in Infusion
  • 9.6 Porter's Five Forces Analysis of the Infusion Pumps Market
    • 9.6.1 Competitive Market Leaders [High]
    • 9.6.2 Threat of New Entrants [Medium]
    • 9.6.3 Power of Suppliers [Medium]
    • 9.6.4 Bargaining Power of Buyers [High]
    • 9.6.5 Threat of Substitutes [Medium]

10. Conclusion

  • 10.1 Infusion Pumps: A Growing Industry
  • 10.2 Current Look at the World Infusion Pumps Market, 2016
  • 10.3 The Global Infusion Pumps Market: Driven or Restrained?

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Report Evaluation Form

List of Figures

  • Figure 1.1 Top Five National Infusion Pumps Market by Revenue, 2016 & 2027
  • Figure 1.2 World Infusion Pumps Market Segmentation Overview, 2016
  • Figure 2.1 Positive Displacement Pump Mechanism
  • Figure 3.1 World Medical Devices Market Forecast: Revenue ($bn) 2016-2027
  • Figure 3.2 World Infusion Pumps Market Forecast: Revenue ($bn), 2016-2027
  • Figure 3.3 World Infusion Pumps Market Forecast: Revenues ($bn) by Segment, 2016-2027
  • Figure 3.4 World Infusion Pumps Market: Market Shares (%) by Segment, 2016
  • Figure 3.5 World Infusion Pumps Market: Market Shares (%) by Segment, 2021
  • Figure 3.6 World Infusion Pumps Market: Market Shares (%) by Segment, 2027
  • Figure 3.7 World Infusion Pumps Market: Drivers and Restraints, 2016-2027
  • Figure 4.1 World Infusion Pumps Market: Revenue ($bn) by Region, 2016
  • Figure 4.2 World Infusion Pumps Market: Market Shares (%) by Region, 2016
  • Figure 4.3 World Infusion Pumps Market Forecast: Comparison between Revenue ($bn) by Region, 2016, 2021, and 2027
  • Figure 4.4 World Infusion Pumps Market Forecast: CAGR (%) by Region in 2016-2021, 2022-2027, and 2016-2027
  • Figure 4.5 World Infusion Pumps Market: Market Shares (%) by Region, 2021
  • Figure 4.6 World Infusion Pumps Market: Market Shares (%) by Region, 2027
  • Figure 4.7 US 65+ Population Forecast: Size (m), 2016-2027
  • Figure 4.8 US Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
  • Figure 4.9 EU5 Infusion Pumps Market: Leading Countries by Revenue ($bn), 2016
  • Figure 4.10 EU5 Infusion Pumps Market: Leading Countries by Market Share (%), 2016
  • Figure 4.11 EU5 Infusion Pumps Market Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 4.12 EU5 Infusion Pumps Market Forecast: Revenues ($bn) by Leading Countries, 2016-2027
  • Figure 4.13 EU5 Infusion Pumps Market Forecast: CAGR (%) by Leading Countries in 2016-2021, 2022-2027 and 2016-2027
  • Figure 4.14 EU5 Infusion Pumps Market: EU Market Shares (%) by Leading Countries, 2021
  • Figure 4.15 EU5 Infusion Pumps Market: EU Market Shares (%) by Leading Countries, 2027
  • Figure 4.16 Germany Infusion Pumps Market Forecast: Revenues ($bn) 2016-2027
  • Figure 4.17 French Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
  • Figure 4.18 UK Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
  • Figure 4.19 Italian Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
  • Figure 4.20 Spanish Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
  • Figure 4.21 Japanese Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
  • Figure 4.22 Chinese Infusion Pumps Market Forecast: Revenues ($bn) 2016-2027
  • Figure 4.23 China's Historical Healthcare Expenditure ($bn), 2001-2010
  • Figure 4.24 Chinese Population: Aged 65 or Over (million) in 1950, 2010 and 2050
  • Figure 4.25 Indian Infusion Pumps Market Forecast: Revenues ($bn) and AGR (%), 2016-2027
  • Figure 4.26 Brazilian Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
  • Figure 4.27 South Korean Infusion Pumps Market Forecast: Revenues ($bn) 2016-2027
  • Figure 4.28 Russian Infusion Pumps Market Forecast: Revenues ($bn), 2016-2027
  • Figure 5.1 Insulin Analogues Submarket: Revenue ($bn) by Leading Products, 2016
  • Figure 5.2 Insulin Analogues Submarket: Leading Products by Market Shares (%), 2016
  • Figure 5.3 Insulin Pumps Submarket: Revenues ($bn) by Region, 2016
  • Figure 5.4 World Insulin Pumps Market: Market Shares (%) by Region, 2016
  • Figure 5.5 Insulin Pumps Submarket Forecast: Revenue ($bn) and AGR (%), 2016-2027
  • Figure 5.6 Insulin Pumps Submarket: Drivers and Restraints, 2016-2027
  • Figure 5.7 Diabetes Prevalence (%) in Leading National Markets, 2016
  • Figure 6.1 Conditions That Require The Use Of Enteral Feeding Pumps, 2016
  • Figure 6.2 Enteral Feeding Pumps Submarket: Revenues ($bn) by Region, 2016
  • Figure 6.3 World Enteral Feeding Pumps Market: Market Shares (%) by Region, 2016
  • Figure 6.4 Enteral Feeding Pumps Submarket: Drivers and Restraints, 2016-2027
  • Figure 7.1 Other Infusion Pumps Submarket Forecast: Revenue ($bn), 2016-2027
  • Figure 7.2 Top 10 Oncology Pharmaceuticals: Revenues ($bn), 2016
  • Figure 7.3 Top 10 Oncology Pharmaceuticals: Market Shares (%), 2016
  • Figure 7.4 Chemotherapy Pumps World Market: Drivers and Restraints, 2016-2027
  • Figure 7.5 Routes of PCA Administration
  • Figure 7.6 PCA Pumps World Market: Drivers and Restraints, 2016-2027
  • Figure 8.1 World Drug Delivery Technologies Market: Revenues ($bn) by Application, 2016
  • Figure 8.2 World Drug Delivery Technologies Market: Market Shares (%) by Application, 2016
  • Figure 8.3 World Drug Delivery Technologies Market: Revenues ($bn) by Country, 2016
  • Figure 8.4 World Drug Delivery Technologies Market: Market Shares (%) by Country, 2016
  • Figure 8.5 Global Drug Delivery Market Forecast: Revenue ($bn) , 2016-2027
  • Figure 9.1 Insulin Delivery Technologies: Average Annual Costs of Usage 2016 ($)
  • Figure 9.2 World Population Aged 65+ Forecast: Population (millions) and AGR (%), 2016-2027
  • Figure 9.3 Porter's Five Forces Analysis of the Infusion Pumps Market, 2016-2027
  • Figure 11.1 Top Five National Infusion Pumps Market by Revenue ($bn), 2016 & 2027
  • Figure 11.2 Main Drivers and Restraints In The Global Infusion Pumps Market, 2016-2027

List of Tables

  • Table 1.1 Infusion Pumps: Leading National Markets Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 2.1 Four Types of Infusion
  • Table 2.2 Advantages and Disadvantages of syringe pumps
  • Table 2.3 Advantages and Disadvantages of Insulin Pumps
  • Table 2.4 Advantages and Disadvantages of Infusion Pumps
  • Table 3.1 World Medical Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 3.1.1 World Medical Devices Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 3.2 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2027
  • Table 3.2.1 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 3.3 Market Shares (%) of Infusion Pumps by Market Segment 2016-2021
  • Table 3.3.1 Market Shares (%) of Infusion Pumps by Market Segment 2022-2027
  • Table 3.4 Percentage of the Population Over 65 Years of Age, 2016-2027
  • Table 4.1 Global Infusion Pumps Market: Revenue ($bn) and Market Shares (%) by Region, 2016
  • Table 4.2 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Region, 2016-2027
  • Table 4.2.1 World Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Region, 2016-2027
  • Table 4.3 World Infusion Pumps Market Forecast: CAGR (%) by Region in 2016-2021, 2022-2027 and 2016-2027
  • Table 4.4 Market Shares (%) of Infusion Pumps Market by Region, in 2016, 2021, and 2027
  • Table 4.4.1Classification of Medical Devices in the United States
  • Table 4.5 US Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.5.1 US Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.6 EU5 Infusion Pumps Market: Revenues ($bn) and EU Market Shares (%) by Leading Countries, 2016-2021
  • Table 4.6.1 EU5 Infusion Pumps Market: Revenues ($bn) and EU Market Shares (%) by Leading Countries, 2022-2027
  • Table 4.7 EU5 Infusion Pumps Market Forecast: Revenues ($bn), AGR (%), Market Share (%) and CAGR (%), 2016-2027
  • Table 4.8 EU5 Infusion Pumps Market Forecast: CAGR (%) by Leading Countries in 2016-2021, 2022-2027 and 2016-2027
  • Table 4.9 EU5 Market Shares (%) of the European Infusion Pumps Market by Leading Countries 2016, 2021, and 2027
  • Table 4.10 Germany Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.10.1 Germany Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.11 French Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.11.1 French Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.12 UK Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.12.1 UK Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.13 Italian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.13.1 Italian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.14 Spanish Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.14.1 Spanish Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.15 Japanese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.15.1 Japanese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.16 Chinese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.16.1 Chinese Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.17 Indian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.17.1 Indian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.18 Brazilian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.18.1 Brazilian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.19 South Korean Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.19.1 South Korean Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 4.20 Russian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 4.20.1 Russian Infusion Pumps Market Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 5.1 Control of Insulin Delivery (Infusion Types and Methods)
  • Table 5.2 Advantages and Disadvantages of Insulin Pumps
  • Table 5.3 Insulin Analogues Submarket: Leading Products by Revenue ($bn) and Market Shares (%), 2016
  • Table 5.4 Insulin Pumps Submarket: Revenue ($bn) and Market Shares (%) by Region, 2016
  • Table 5.5 Insulin Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 5.5.1 Insulin Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 5.6 Leading Products in the Insulin Pumps Submarket, 2016
  • Table 5.7 Key Pipeline Products for Insulin Pumps Submarket, 2016
  • Table 5.8 Diabetes Prevalence (m) in Leading National Markets, 2016
  • Table 6.1 Advantages and Disadvantages of Enteral Feeding, 2016
  • Table 6.2 Types of Tubes Used in Enteral Feeding, 2016
  • Table 6.3 Enteral Feeding Pumps Submarket: Revenues ($bn) and Market Shares (%) by Region, 2016
  • Table 6.4 Enteral Feeding Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 6.4.1 Enteral Feeding Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 6.5 Leading Products in the Enteral Feeding Pumps Submarket, 2016
  • Table 6.6 Other Products in the Enteral Feeding Pumps Submarket, 2016
  • Table 7.1 Other Infusion Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2016-2021
  • Table 7.1.1 Other Infusion Pumps Submarket Forecast: Revenues ($bn), AGR (%) and CAGR (%), 2022-2027
  • Table 7.2 Advantages and Disadvantages of Chemotherapy Pumps
  • Table 7.3 Oncology Pharmaceuticals: Revenue ($bn) and Market Shares (%), 2016
  • Table 7.4 Top 10 Oncology Pharmaceuticals: Key Facts
  • Table 7.5 Leading Products in the Chemotherapy Pump Market, 2016
  • Table 7.6 Advantages and Disadvantages of PCA Pumps
  • Table 7.7 Leading Products in the PCA Pumps Market, 2016
  • Table 7.8 Other Noticeable PCA Pumps
  • Table 8.1 World Drug Delivery Technologies Market: Revenue ($bn) and Market Shares (%) by Application, 2016
  • Table 8.2 World Drug Delivery Technologies Market: Revenue ($bn) and Market Shares (%) by Country, 2016
  • Table 8.3 World Drug Delivery Technologies Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Application, 2016-2021
  • Table 8.3.1 World Drug Delivery Technologies Market Forecast: Revenues ($bn), AGR (%) and CAGR (%) by Application, 2022-2027
  • Table 8.4 Key Pipeline Products for Oral Delivery, 2016
  • Table 8.5 Key Pipeline Products for Transdermal, Transmucosal, and Implantable Delivery, 2016
  • Table 8.6 Key Pipeline Products for Inhaled and Injectable Delivery, 2016
  • Table 9.1 SWOT Analysis of World Infusion Pumps Market 2016-2027
  • Table 9.2 Average Initial Costs Associated With Insulin Pump Use 2016 ($)
  • Table 9.3 Insulin Delivery Technologies: Average Annual Costs of Usage 2016 ($)
  • Table 9.4 Infusion Pumps and Related Products Recall in the US, 2007-2016

Companies Listed

  • Abbott Nutrition
  • Akas Medical
  • Alcor Scientific
  • Alkermes
  • Allied Medical
  • Altea Therapeutics
  • Amsino International
  • Animas Corporation
  • Aradigm
  • Asante
  • B. Braun
  • Baxter
  • Bayer Healthcare
  • Becton & Dickson & Co
  • Bio-Med
  • BMS
  • Boston Scientific Corporation
  • Calibra Medical
  • Cardinal Health
  • CareFusion
  • Celgene
  • Cellnovo
  • Celsus Laboratories
  • CeQur
  • CME Medical
  • Codman and Shurtleff
  • Conmed Corporation
  • Cook Medical
  • Covidien
  • D. Medical Industries
  • Danone Nutricia
  • Debiotech
  • DePuy
  • Disetronic Medical Systems
  • DreaMed Diabetes
  • Eli Lilly
  • Emco
  • Emisphere
  • Fresenius Kabi
  • GE Medical
  • Generex Biotechnology Corporation
  • Glycologic
  • Hanraj Nayyar Medical India
  • Hospira
  • IBM
  • I-Flow
  • Insulet Corporation
  • Intercell
  • Johnson and Johnson
  • Kimberly Clark Corporation
  • Medingo
  • Medsolve Technologies
  • Medtronic
  • Micrel Medical Devices
  • Mindray
  • Moog
  • NeoDevices
  • NeoMed
  • Nestle Healthcare
  • NiliMEDIX
  • Novartis
  • Noven Pharmaceuticals
  • NovoNordisk
  • Pacira Pharmaceuticals
  • Philips Medical
  • pSivida Corporation
  • Q Core Medical
  • Roche
  • Sanofi
  • Schiller
  • Smith Medical
  • SOOIL
  • Symbios Medical Products
  • Takeda
  • Tandem Diabetics Care
  • Tandem Diagnostics
  • Terumo Medical Corporation
  • Trivitron
  • Valeritas
  • Vectura
  • Vishal Surgical
  • WalkMed Inc
  • Zevex

List of Organizations Mentioned in the Report

  • Agência Nacional de Vigilância Sanitária (ANVISA)
  • American Medical Devices and Diagnostic Association (AMDD)
  • Center for Devices and Radiological Health (CDRH)
  • Centres for Medicare and Medicaid Service (CMS)
  • China Food and Drug Administration (CFDA)
  • China's National Health and Planning Commission (NHPC)
  • Chinese Ministry of Science and Technology
  • Government Accountability Office (GAO)
  • Japanese Ministry of Health, Labour and Welfare (MHLW)
  • Juvenile Diabetes Research Foundation
  • Medical Devices Information & Technology Assistance Centre (MDITAC)
  • Medicines and Healthcare products Regulatory Agency (MHRA)
  • National Competent Authorities (NCAs)
  • National Diabetes Education Program (NDEP)
  • National Institute for Health and Clinical Excellence (NICE)
  • National Medical Devices Authority (NMDA)
  • NHS England
  • Ningbo First Hospital
  • Roszdravnadzor
  • Sahlgrenska Academy
  • Servicio Sanitario Nazionale (SSN)
  • South Korean Ministry for Food and Drug Safety (MFDS)
  • South Korean Ministry of Health and Welfare (MOHW)
  • South Korean Ministry of Science, ICT and Future Planning (MSIP)
  • South Korean Ministry of Trade, Industry and Energy (MOTIE)
  • Único de Saúde (SUS)
  • United Nations Population Division
  • United States Food and Drug Administration (FDA)
  • US Department of Health and Human Services
  • World Bank
  • World Health Organization (WHO)
Back to Top